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Alternative pre-mRNA splicing plays fundamental roles in neurons by generating functional diversity in proteins
associated with the communication and connectivity of the synapse. The CI cassette of the NMDA R1 receptor is one of
a variety of exons that show an increase in exon skipping in response to cell excitation, but the molecular nature of this
splicing responsiveness is not yet understood. Here we investigate the molecular basis for the induced changes in
splicing of the CI cassette exon in primary rat cortical cultures in response to KCl-induced depolarization using an
expression assay with a tight neuron-specific readout. In this system, exon silencing in response to neuronal excitation
was mediated by multiple UAGG-type silencing motifs, and transfer of the motifs to a constitutive exon conferred a
similar responsiveness by gain of function. Biochemical analysis of protein binding to UAGG motifs in extracts
prepared from treated and mock-treated cortical cultures showed an increase in nuclear hnRNP A1-RNA binding
activity in parallel with excitation. Evidence for the role of the NMDA receptor and calcium signaling in the induced
splicing response was shown by the use of specific antagonists, as well as cell-permeable inhibitors of signaling
pathways. Finally, a wider role for exon-skipping responsiveness is shown to involve additional exons with UAGG-
related silencing motifs, and transcripts involved in synaptic functions. These results suggest that, at the post-
transcriptional level, excitable exons such as the CI cassette may be involved in strategies by which neurons mount
adaptive responses to hyperstimulation.
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Introduction
Alternative pre-mRNA splicing expands protein functional
diversity by directing precise nucleotide sequence changes
within mRNA coding regions. Splicing regulation often
involves adjusting the relative levels of exon inclusion and
skipping patterns as a function of cell type or stage of
development. In the nervous system, such changes affect
protein domains of ion channels, neurotransmitter receptors,
transporters, cell adhesion molecules, and other components
involved in brain physiology and development [1,2].
There is growing evidence that various biological stimuli,
such as cell excitation, stress, and cell cycle activation, can
induce rapid changes in alternative splicing patterns [3,4].
These phenomena suggest that splicing decisions may be
altered by communication between signal transduction
pathways and splicing machineries, but such molecular links
and mechanisms are largely unknown. The focus of the
present study is to gain insight into these mechanisms using
primary neurons as the model system.
Splicing decisions take place in the context of the
spliceosome, which is the dynamic ribonucleoprotein machi-
nery required for catalysis of the RNA rearrangements
associated with intron removal and exon joining [5–7].
Spliceosomes assemble on pre-mRNA templates by the
systematic binding of the small nuclear ribonucleoprotein
particles, U1, U2, and U4/U5/U6, which leads to splice site
recognition and exon definition. Thus, splicing decisions can
be profoundly influenced by the strength of the individual 59
and 39 splice sites and by auxiliary RNA sequences that tune
splice site strength via enhancement or silencing mechanisms.
RNA binding proteins from the serine/arginine-rich (SR) and
heterogeneous nuclear ribonucleoprotein (hnRNP) families
play key roles in recognizing auxiliary RNA sequences from
sites within the exon (exonic splicing enhancers or silencers;
ESEs or ESSs, respectively) or intron (intronic enhancers or
silencers; ISEs or ISSs, respectively). Despite numerous RNA
motifs that have been functionally characterized as splicing
enhancers or silencers, the mechanisms by which these motifs
function in combination to adjust splicing patterns are not
yet well understood [8,9]. The broad significance of this
problem is highlighted by the observation that nearly 75% of
human pre-mRNAs with multiple exons undergo alternative
splicing [10]. In addition, numerous point mutations in splice
sites or splicing control elements have been linked to genetic
disease [11].
Insights into the molecular basis for induced effects on
alternative splicing have come from a variety of biological
systems. Cell excitation by KCl-induced membrane depolari-
zation in the pituitary cell line, GH3, has been shown to
induce skipping of several cassette exons, including the
STREX exon of the BK slo channel, as well as the N1 and
C1 exons of the glutamate NMDA receptor NR1 subunit
(GRIN1 gene) [12]. Note that the CI cassette exon is called
exon 21 in other studies. Calcium/calmodulin kinase (CaMK)
IV was implicated in these effects based on the loss of
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excitation-induced exon skipping by a specific inhibitor of
this enzyme, whereas the reverse effect was observed by
expression of the catalytic subunit of the enzyme. In this
study, a 54-nucleotide region of the 39 splice site of the
STREX exon was identified and found to be sufficient to
mediate similar effects when attached to a heterologous exon.
In another study, application of the drug pilocarpine induced
skipping of the EN exon of clathrin light chain B, the N1 exon of
c-src, and the CI exon of GRIN1 transcripts in the rat
hippocampus and/or cortex of living animals [13]. In the T
cell–derived cell line JSL1, phorbol ester treatment has been
shown to induce cell excitation together with increased
skipping of exon 4 of CD45 pre-mRNA. These effects are
dependent upon a 60-nucleotide splicing silencer within exon
4, and hnRNP L has been implicated as a factor involved in
mediating these effects [14,15]. In another study, phorbol
ester has been shown to increase CD44 v5 exon inclusion in a
manner that was dependent upon Sam68 and the MAPK/ERK
pathway [16]. In HeLa cells, the cellular response to heat
shock was found to generate potent and widespread splicing
silencing, and SRp38 was identified as the protein factor
responsible for these effects [17]. A general silencing effect on
pre-mRNA splicing by SRp38 was also observed in cells
undergoing mitosis [18].
Recent studies have implicated hnRNP A1 as a factor that
mediates induced changes in alternative splicing in response
to osmotic stress. NIH 3T3 cells that have undergone osmotic
stress have a relative increase in cytoplasmic A1 compared to
nuclear A1, and this effect is associated with the phosphor-
ylation of carboxy terminal residues that extend into the M9
region [19,20]. HnRNP A1 has been shown to regulate a
variety of alternative splicing events through the recognition
of RNA sequences related to the consensus binding motif,
UAGGGA/U [11,21,22]. Two RNA binding domains and a
glycine-rich region are involved in sequence-specific recog-
nition, and a sequence near the carboxyl terminus, M9, is
required for nuclear import. HnRNP A1 has been shown to
function as a substrate for protein kinase C (PKC), protein
kinase A (PKA), and casein kinase [23]. HnRNP A19s ability to
silence splicing of CD44 v5 exon was reduced by the
overexpression of a constitutively active form of the
mitogen-activated protein/ERK kinase kinase 1, and by the
small GTP-binding protein Cdc42 in NIH 3T3 and eryth-
roleukemia cell lines [24]. Together, these results suggest that
the functional properties of hnRNP A1 could be altered in
complex ways through signaling pathways in response to
various biological stimuli.
The CI cassette exon of the GRIN1 gene was chosen for this
study based on its known hnRNP A1–mediated exon silencing
mechanism, which involves two exonic UAGGs and an
intronic GGGG motif [25]. Here we develop a system to
study the response of the CI cassette to cell excitation in
neurons of primary cultures, and we utilize this system to
investigate the role of the UAGG-related exon silencing code
in the induced exon-skipping response. We extend this with
complementary biochemical approaches to test for binding-
and expression-level effects on hnRNP A1 protein in nuclear
extracts prepared from resting and excited cultures. We also
take advantage of the primary neuronal cultures to explore
the role of endogenous ion channels in the induced exon-
skipping phenomenon using antagonists of the NMDA
receptor and other physiologically relevant calcium channels.
An expanded analysis of exon-skipping responsiveness of
endogenous transcripts involved in synaptic and non-synap-
tic functions is also presented.
Results
Assay for Activity-Induced Alternative Splicing in Primary
Neurons and Glia Using Reporters Driven by Cell-Specific
Promoters
Primary neurons, due to their responsiveness and plasti-
city, should represent a useful model system to study activity-
induced changes in alternative splicing, but to date, such
systems have not been well developed. In this study, we have
developed low-density cortical cultures from the embryonic
rat forebrain as an experimental system to address the
molecular mechanisms of induced changes in alternative
splicing using cell-specific and biochemical approaches.
Upon dissociation and plating in culture, the postmitotic
neurons extend processes, establish synaptic connections,
and become electrically active, whereas glial cells in these
cultures play supportive roles.
Initially, changes in endogenous splicing patterns were
monitored in the cortical cultures both as a function of KCl-
induced depolarization, and cell differentiation using the CI
cassette exon as a readout. The cortical cultures at 6, 8, 12,
and 14 d in vitro (DIV) after plating were treated for 24 h with
media containing 25 or 50 mM KCl, since these conditions are
known to induce membrane depolarization in these cultures.
Changes in the percent exon inclusion values were calculated
as the difference between the value in the 50 mM KCl sample
and the mock-treated control (DEI values).
Each stage of differentiation of the cultures showed similar
trends in which CI cassette exon inclusion decreased (DEI,
32% to36%; Figure 1, lanes 1–12) as a function of the KCl
treatment. Based on the consistent response of each exon in
this time frame, we used the cultures to ask whether KCl
treatment produces transient or stable changes in the splicing
patterns of the endogenous RNA transcripts. If transient
changes in transcriptional or post-transcriptional events
Author Summary
The modular features of a protein’s architecture are regulated after
transcription by the process of alternative pre-mRNA splicing.
Conditions that excite or stress neurons can induce changes in
some splicing patterns, suggesting that cellular pathways can take
advantage of the flexibility of splicing to tune their protein activities
for adaptation or survival. Although the phenomenon of the
inducible splicing switch (or inducible exon) is well documented,
the molecular underpinnings of these curious changes have
remained mysterious.
We describe methods to study how the glutamate NMDA
receptor, which is a fundamental component of interneuronal
signaling and plasticity, undergoes an inducible switch in its splicing
pattern in primary neurons. This splicing switch promotes the
skipping of an exon that encodes the CI cassette protein module,
which is thought to communicate signals from the membrane to the
cell nucleus during neuronal activity. We show that this induced
splicing event is regulated in neurons by a three-part (UAGG-type)
sequence code for exon silencing, and demonstrate a wider role for
exon-skipping responsiveness in transcripts with known synaptic
functions that also harbor a similar sequence code.
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affect splicing factors involved in these mechanisms, we
would expect to see a reversal to the basal splicing pattern
with time after removal of the stimulus. Reversibility was
tested in the 12-d cultures, again using the CI cassette splicing
events as a readout. After treatment with KCl, the cultures
were changed to fresh medium without KCl, and cells were
harvested 0, 6, 12, and 24 h later. KCl-induced changes in the
splicing of the CI cassette exon progressively lessened with
time to approximately basal levels after KCl washout (DEI,
8%; Figure 1, lanes 13–24).
For comparison, we assayed for the effects on alternative
exon 9 (E9) of the GABAA receptor c2 (GABARG2 gene) in the
same cultures, since E9 is known to undergo silencing by the
polypyrimidine tract binding protein, but not hnRNP A1
(Figure S1A). Interestingly, E9 inclusion was responsive to the
KCl treatment, but this effect was maximized at longer
differentiation times of the cultures, and, in contrast to the CI
cassette, E9 inclusion increased (DEI, 23%, lanes 1–12). These
effects were also largely reversible after KCl washout (lanes
13–24). Thus, the KCl-induced effects on CI cassette and E9
inclusion are largely reversible, and suggest a role for mRNA
homoeostasis in allowing for the readjustment of splicing
patterns to basal levels.
To experimentally identify nucleotide sequence require-
ments for activity-induced alternative splicing in neuronal
and glial cell types in the cortical cultures, we turned to cell-
specific promoters that were previously characterized in
transgenic mice. For this purpose, we assessed the ability of
the alpha CaMKII promoter to drive neuron-specific ex-
pression in rat cortical cultures, since this promoter was
shown previously to drive forebrain-specific expression in
excitatory neurons of transgenic mice [26]. Fluorescent
reporters were constructed in which the expression of
enhanced yellow fluorescent protein (EYFP) was driven by
various portions of the CaMKII promoter (Figure 2, con-
structs 1 and 2). Construct CaMKII_279 EYFP contained an
8.5-kilobase (kb) promoter region known to restrict expres-
sion of Cre to the forebrain of transgenic mice. For cloning
Figure 1. Reversibility and Effects of Neuronal Differentiation in the Response of the CI Cassette Exon to KCl-Induced Depolarization in Rat Cortical
Cultures
Alternative splicing of the endogenous CI cassette exon (NMDA R1 transcript) was monitored in rat cortical cultures in response to KCl treatment
beginning at day 6 (lanes 1–3), 8 (lanes 4–6), 12 (lanes 7–9), and 14 (lanes 10–12) after plating. Cell cultures were treated with 0, 25, or 50 mM KCl in the
culture medium for 24 h. Reversibility of induced effects was monitored in day 12 cultures, which were treated with 0, 25, and 50 mM KCl for 24 h
followed by washout into fresh medium without KCl for an incubation time of 0 (lanes 13–15), 6 (lanes 16–18), 12 (lanes 19–21), and 24 (lanes 22–24) h
after washout. Relative quantities of exon-included (,,) and -skipped (,) mRNA products were measured by RT-PCR. A minimum number of three
measurements were used to calculate each mean. Graph shows percent exon inclusion as a function of the KCl treatment and differentiation of the
cultures. Representative results are shown in the gel panels. The percent change in exon inclusion (DEI) was calculated as follows: the percent exon
inclusion in the 50 mM KCl sample minus the percent exon inclusion in the 0 mM KCl sample.
doi:10.1371/journal.pbio.0050036.g001
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purposes, a shorter promoter region was also tested, which
contained the start site–proximal 2.2-kb promoter fragment
(CaMKII_22 EYFP).
To determine expression patterns in the cortical cultures,
confocal microscopy was used to measure the extent of
overlap between EYFP expression and antibody staining with
TRITC-labeled NeuN or glial fibrillary associated protein
(GFAP), which served as molecular markers for neurons and
Figure 2. Promoters from Transgenic Mice Drive Neuron- and Glial-Specific Expression in Cortical Cultures
(A) Schematic of reporter constructs and results of fluorescent reporter overlap with molecular markers. Full-length (8.5 kb; CaMKII_279), and shortened
(2.2 kb; CaMKII_22) mouse alpha CaMKII promoters were fused to the open reading frame of EYFP (constructs 1 and 2). Restriction sites used for the
promoter deletions or for insertion of the fluorescent reporter coding sequence are indicated. The glial-specific Gfa2 promoter was fused to DsRed
(construct 3). The CMV promoter fused to EYFP (construct 4) or DsRed (construct 5) were used as controls. Numbers at right indicate the percentage of
fluorescent cells that showed overlap expression with NeuN or GFAP antibody staining. For each percentage, the total number of fluorescent cells
counted for antibody staining (n) is indicated.
(B) Summary of experimental scheme and representative results. Following transfection, cortical cultures were fixed and stained with antibody for
molecular marker as indicated using a FITC or TRITC conjugated secondary antibody (left panel). To measure overlap expression, cells expressing the
EYFP (or DsRed) fluorescent reporter were localized, then switched to the channel for detection of TRITC (or FITC) label. Representative results are
shown for CaMKII and Gfa2 reporters (right panels). Cells expressing CaMKII EYFP reporters are green; antibody staining is red (TRITC-anti-Neu N, top
panels; TRITC-anti-GFAP, bottom panels). Note that the NeuN marker is restricted to the cell nucleus as expected. Cells expressing the Gfa2 DsRed
reporter are red; antibody staining is green. Yellow signifies expression overlap.
(C) Graphical summary of the fluorescent reporter expression. The y-axis represents the percent expression overlap of the fluorescent reporter and
antibody staining for neurons (NeuN) or glia (GFAP). The x-axis represents promoter constructs from (A).
doi:10.1371/journal.pbio.0050036.g002
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glia, respectively (Figure 2B). For comparison, we also
constructed a fluorescent reporter in which DsRed was fused
to a 2-kb region of the Gfa2 promoter, Gfa2 DsRed (Figure 2,
construct 3) [27]. The Gfa2 promoter was shown previously to
drive expression predominantly in glial cells of transgenic
mice [28]. As controls, the EYFP and DsRed coding sequences
were also fused to the human cytomegalovirus immediate
early (CMV) promoter (Figure 2, constructs 4 and 5).
The strong neuron specificity of expression of the CaMKII
promoters in these cultures is shown as the percent overlap
expression of each construct with NeuN or GFAP antibody
staining (Figure 2A, top right). For each sample, a minimum
of 200 cells with EYFP fluorescence were examined for
TRITC-labeled NeuN staining. Whereas, the largest (8.5 kb)
region of the promoter (CaMKII_279) showed 96% overlap
with NeuN and 3% overlap with GFAP, similar results were
observed with the 2.2-kb region (CaMKII_22; 95% overlap
with NeuN and ;5% overlap with GFAP). In contrast, the
Gfa2 promoter was preferentially expressed in glia in these
cultures (94%), and some overlap with neurons was observed
(22%) in agreement with previous analysis in transgenic mice
[28]. A summary of these results is also shown graphically
(Figure 2C). As a reference, EYFP expressed from the CMV
promoter (CMV_EYFP) showed 64% overlap with NeuN and
21% overlap with GFAP, whereas the DsRed expressed from
the same promoter (CMV_DsRed) showed 54% overlap with
NeuN and 26% overlap with GFAP. Due to its mixed
expression profile, the CMV promoter was not used for
further analysis.
Representative examples of the overlap expression of the
two CaMKII EYFP reporters with NeuN is shown in Figure 2B.
Overlap expression is indicated by yellow fluorescence in the
nuclei of samples stained with TRITC-labeled anti-NeuN
(CaMKII EYFP reporters, anti-NeuN panels), and the lack of
overlap expression in samples containing the anti-GFAP
antibody is clearly shown (anti-GFAP panels). The pattern of
expression for samples containing the Gfa2 DsRed reporter
characteristically showed overlap of DsRed fluorescence with
FITC-labeled anti-GFAP, but not with FITC-labeled anti-
NeuN (Gfa2 DsRed panels).
To confirm the neuron- versus glial-specific expression
patterns of the promoters, we co-transfected the CaM-
KII_22_EYFP and Gfa2-DsRed plasmids into the same
cortical cultures and determined overlap expression. No
greater than 22% overlap would be expected based on the
least specific of the two promoters, Gfa2. The observed
overlap ranged from 14% to 19% (raw values), in contrast to
82% to 84% from the generally expressed CMV promoters.
After normalizing these values to 100% transfection effi-
ciency for the CMV samples, the co-expression of CaMKII
and Gfa2 promoters ranged from 17% to 23% (corrected
values). These results are in good agreement with the
promoter selectivity shown above.
We next asked how these promoters affect splicing patterns
in established neuronal (PC12 and ST15A) and muscle
myoblast (C2C12) cell lines, in comparison to the primary
cortical cultures. Similar CI cassette exon inclusion levels
were observed from the two promoter types in the neuronal
and non-neuronal cell types (DEI, ,3.6%, Table 1). Thus, the
increase in CI cassette exon inclusion arising from the
promoter fusions in primary cortical cultures must reflect the
properties of the neurons and glial cells in the cultures, and
cannot be explained by the promoters alone.
Next we took advantage of the CaMKII and Gfa2 splicing
reporters to characterize the KCl-induced effects on CI
cassette exon silencing as a function of cell type in the
primary cortical cultures. Wild-type CI cassette splicing
reporters driven by the cell-specific promoters CaMKII_22
CI wt0 and Gfa2 C1 wt0 were transiently expressed in cortical
cultures for 18 h, followed by treatment with KCl for 6 and 24
h. When transcripts were expressed from the CaMKII_22
promoter, CI cassette exon inclusion decreased in response
to the KCl treatment, and this effect was consistent in
neurons at all time points examined (Figure 3A, lanes 7–12).
Similar effects were observed for the endogenous CI cassette
exon when mock-transfected cultures were treated in parallel
(lanes 1–6). Optimal effects were reached after 24 h for both
endogenous and CaMKII_22-expressed transcripts. In con-
trast, when transcripts were expressed from the Gfa2
promoter, CI inclusion showed little or no change at the 6-
and 24-h time points (lanes 13–18). Based on the cell
specificity of the CaMKII promoter shown above, we
conclude that neurons play the predominant role in the
KCl-induced changes in alternative splicing in these cultures.
Furthermore, the trend and magnitude of the effects for the
exogenous CI cassette exon inclusion are in good agreement
with those of the endogenous transcripts. As a corollary to
this experiment, we measured the number of CaMKII_EYFP-
expressing neurons that fail to exclude trypan blue. In mock-
and depolarization-treated cultures, we observed that the
viability of the neurons was high in both the mock-treated
(94% viable) and depolarization-treated (93% viable) samples
(Figure 3B). Thus, we conclude that the RT-PCR results shown
above (Figure 3A, lanes 7–12) largely reflect splicing pattern
changes in viable neurons.
To further validate these results, we transferred the E9
splicing reporter into the CaMKII and Gfa2 promoter
constructs and tested their response to KCl treatment in
the cortical cultures (Figure S1B). When expression was
driven in neurons, E9 inclusion increased similarly to that of
the endogenous transcripts (DEI, 17% and 15%, respectively),
but this was not the case when expression was driven in glial
cells (DEI, 3%). Thus, for a second test exon, the promoter
Table 1. Effects of Cell-Specific Promoters on Alternative Exon
Inclusion in Cell Lines versus Cortical Cultures for the Splicing
Reporter CI wt0
Promoter Cells Percent CI Cassette
Exon Inclusion
DEI
Percent
CaMKII_22 PC12 cell linea 23.7 1.9
Gfa2 21.8
CaMKII_22 ST15A cell linea 27.4 3.6
Gfa2 31.0
CaMKII_22 C2C12 cell linea 27.9 2.0
Gfa2 29.9
CaMKII_22 Primary cortical culturesb 35.0 21.0
Gfa2 14.0
aPC12 and ST15A, neuronal cell lines; C2C12, muscle myoblast cell line.
bResults obtained from cortical cultures at 2 DIV.
doi:10.1371/journal.pbio.0050036.t001
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system recapitulated the splicing response in neurons as
observed for the endogenous transcripts.
Identification of RNA Sequence Motifs That Mediate the
Response of Exon Skipping to Neuronal Activity
Based on the well-behaved exon-skipping response of the
CI cassette exon to KCl-induced depolarization in this system,
we focused on this exon to identify nucleotide sequences
involved in the response. A three-component code of two
exonic UAGGs and an intronic GGGG motif, which was
recently shown to mediate CI cassette exon silencing [29],
served as the starting point for these experiments. Splicing
reporters with point mutations in combinations of the three
silencing motifs were subcloned under the control of the
CaMKII_22 promoter, and assayed in the cortical cultures
(Figure 4A).
In the absence of KCl treatment, the CI wt0 reporter with
intact UAGG and GGGG motifs showed strong silencing
activity (exon skipping) in the primary neurons in agreement
with our previous analysis in cultured cell lines. Compared to
the wild-type substrate, point mutations in a single silencer
increased exon inclusion (Figure 4A, lanes 1, 4, 7, and 13), and
multiple point mutations generated complete or nearly
complete exon inclusion (lanes 10 and 16). In results new to
this study, the UAGG and GGGG silencer motifs were found to
be important for the depolarization-induced effects on exon
skipping in the primary neurons. A complete disruption of
KCl-induced exon skipping was associated with point muta-
tions in two ormore of the silencingmotifs (substrates E17 and
T8; lanes 10–12 and 16–18). In contrast, an increase in exon
skipping occurred in parallel with the depolarization treat-
ment for the wild-type substrate (DEI,17%; lanes 1–3). Point
mutations in single motifs showed a similar trend in which the
KCl-induced effects on exon skipping were disrupted at
various levels (substrates E8, E9, and D0; lanes 4–9 and 13–
15). We next tested the role of exonic enhancer motifs in the
same fashion, since these motifs function generally to
antagonize exon silencing. The sequence, type, and position
of the exonic enhancermotifs and their inactivatingmutations
are shown in Figure 4B. Of the six mutants, E2, E3, E4, and E5
showed reduced basal levels of CI exon inclusion in neurons,
and the response of these exons to KCl-induced depolarization
was either similar to (E6 and 5m1, lanes 34–39) or reduced (E2,
E3, E4, and E5, lanes 22–33) compared to the wild-type CI
cassette (lanes 19–21). These results suggest that sequences
outside of the UAGGmotifs in the exon may also play a role in
the induced splicing silencing response.
To validate these results, we asked whether a multicompo-
nent UAGG silencing motif code is sufficient to confer
sensitivity to KCl-induced depolarization; we introduced
UAGG motifs into exon 5 of the gene encoding the human
Dip13 beta adapter protein (DIP13B_HUMAN). This exon
was chosen based on the use of algorithms that predicted
strong 59 and 39 splice sites, a moderate number of exonic
enhancer motifs (n¼10), and a lack of known exonic silencing
motifs (MaxEntScan, ACEScan, and ESEFinder). Another
attractive feature was the clustered arrangement of predicted
enhancermotifs that allowed for the insertion of UAGGmotifs
at multiple discrete positions. The region containing exon 5
and its flanking splice sites was cloned into a chimeric splicing
reporter by replacing the middle exon of the previously
described SIRT1a plasmid [29], and the promoter was replaced
with CaMKII_22 to direct expression in neurons (Figure 5A,
DIP13_E5). When expressed in neurons, the DIP13_E5
splicing reporter was nearly insensitive to the excitation
treatment (DEI, 0%; Figure 5B, lanes 1–3). In order to test the
role of the silencing motif pattern in the response to
excitation, we next introduced three exonic UAGG motifs
and a 59 splice site GGGG motif (DIP_3aG). Introduction of
the silencingmotif pattern indeed generated an exon-skipping
pattern in resting neurons (61% exon inclusion), and in the
presence of KCl treatment to induce excitation, exon inclusion
progressively decreased to 45% (DEI, 16%; lanes 4–6). In
another variant, DIP_E2, point mutations were introduced
into the exon to destroy overlapping SC35 and ASF-SF2motifs
near the 39 end of the exon (Figure 5A). For DIP_E2, exon
inclusion decreased in resting neurons, and the response to
excitation was similar to that observed for DIP_3aG (Figure
5B, lanes 7–9). Thus, we conclude that a multicomponent
UAGG silencing motif code is sufficient to generate induced
exon skipping in response to KCl-induced depolarization.
Biochemical Analysis of Protein Binding to Silencing
Motifs in Nuclear Extracts from Resting and Excited
Cultures
We reasoned that factors known to be involved in splicing
silencing via UAGG silencing motifs in resting cells would be
likely candidates to mediate the induced splicing silencing
response in excited neurons. Alternatively, excitation might
weaken the role of factors involved in antagonizing this
silencing mechanism. We initially focused on hnRNP A1 to
probe for changes in regulatory factors, because our previous
work demonstrated direct binding of this factor to the UAGG
motifs in HeLa nuclear extracts, and because its silencing
effect in vivo was dependent upon the intact motif pattern.
To attempt to visualize whether changes in hnRNP A1
accompany KCl-induced depolarization, RNA-protein bind-
ing assays were used as sensitive readouts. In these experi-
ments, 5-d cortical cultures were treated with KCl in the
medium to induce depolarization, and cells were harvested
for preparation of small-scale nuclear extracts (see Materials
and Methods). The time of KCl treatment was shortened from
24 h to 12 h based on the expectation that any excitation-
induced alterations to splicing factors should precede the
splicing pattern shifts themselves.
Ultraviolet (UV) crosslinking was used to monitor direct
protein binding to 59[32P]-labeled RNA oligonucleotides
under splicing conditions, and the crosslinked proteins were
resolved by SDS-PAGE. A 22-mer containing three UAGG
motifs showed increased crosslinking of a 34-kDa protein,
suggestive of hnRNP A1, in nuclear extracts prepared from
KCl-induced versus mock-treated samples (Figure 6A, lanes 1
and 2). Increased crosslinking of the 34-kDa protein in the
KCl-induced extracts was observed in eight different nuclear
extract preparations, and the fold increase was in the range of
1.5- to 2.5-fold. To determine whether hnRNP A1 was
responsible for the observed increase in crosslinking, a size-
matched control RNA with point mutations in the UAGG
motifs (A1 mutant) was tested in parallel reactions. Cross-
linking of the 34-kDa protein to the A1 mutant oligo was
abolished, demonstrating that intact UAGGs are essential for
binding. To confirm the identity of the 34-kDa protein, three
UV crosslinking reactions equivalent to that shown in lane 2
were combined and immunoprecipitated with monoclonal
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Figure 3. Cell-Specific Splicing Reporter Assay for Depolarization Induced Alternative Splicing and Effects on Cortical Neuron Viability
(A) Changes in C1 cassette exon inclusion in response to depolarization were measured by transfecting CaMKII_22 and Gfa2 C1 wt0 splicing reporters
into day 5 (DIV) cortical cultures, followed by addition of KCl (25 mM or 50 mM) into the culture medium for 6 or 24 h to induce depolarization. Inset
summarizes order of addition. Control cultures were mock treated in parallel (0 mM KCl). Splicing patterns were determined from RNA harvested from
the samples by RT-PCR using forward primers (rightward arrows) specific for transcripts expressed from CaMKII_22 (1) and Gfa2 (2), together with a
common reverse primer specific for the C2 exon (leftward arrow). Endogenous transcripts were amplified similarly with a forward primer (E) together
with the C2-specific primer. A minimum number of three measurements were used for each mean and standard deviation shown. Structures of the
splicing reporters are shown; exon numbers are based on the human GRIN1–006 transcript (schematic, top). Bar graphs represent percent C1 exon
inclusion at two time points (6 and 24 h) after addition of KCl. Representative gels are shown (bottom). Effects on splicing reporters, (1) CaMKII_22 (lanes
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antibody 9H10, which is specific for hnRNP A1. These results
showed that, relative to the control antibody, the 34-kDa
crosslinked protein was partitioned into the pellet (and
depleted from the supernatant) in the presence of 9H10,
supporting its identification as A1 (Figure S2). For compar-
ison, parallel crosslinking reactions with distinct RNA oligos
specific for human Tra2 and ASF/SF2 were also tested, but
these proteins showed no detectable change in binding in
extracts prepared from the KCl-induced versus mock-treated
cultures.
Enhanced hnRNP A1 binding was also observed for the full-
length CI cassette exon in UV crosslinking reactions prepared
with nuclear extracts from KCl-induced cultures (Figure 6A.
lanes 9 and 10). Note that the full-length CI cassette exon
tested here contains three UAGGs distributed throughout the
111-nucleotide exon, which is a less-concentrated motif
arrangement relative to the A1 oligo. In contrast to hnRNP
A1, higher molecular weight proteins in the 57- to 100-kDa
range in these samples serve as reference comparisons, since
these displayed similar crosslinking levels in the two nuclear
extracts (lanes 9 and 10, Ref bands). The identity of hnRNP
A1 was verified by competition experiments with unlabeled
A1 oligo, which reduced crosslinking to the 34-kDa protein in
a concentration-dependent manner (unpublished data).
To verify the change in hnRNP A1 binding observed in the
UV crosslinking assay, affinity selection was used as a
complementary method. For this experiment, the full-length
CI cassette exon with three UAGGs was subcloned upstream
of the M3 hairpin to provide an affinity tag that was specific
for the MS2-MBP fusion protein [30]. The CI cassette exon
was subcloned without the M3 hairpin as a control. To assay
for hnRNP A1, one half of the eluted samples were separated
by SDS-PAGE and immunoblotted with the 9H10 antibody.
Parallel blots of the second half of the samples were
developed with an antibody specific for ASF/SF2. Binding of
hnRNP A1 was dependent upon the presence of the M3
hairpin (Figure 6B, lanes 13–16), and an increase (1.5-fold) in
A1 binding to the M3_E18 substrate was observed in the
KCl-induced versus mock-treated extracts (lanes 13 and 14).
This difference in A1 was similar in the input samples prior
to RNA binding (lanes 11 and 12). The increase in the level of
A1 protein was similar to the input samples prior to RNA
binding. In contrast, ASF/SF2 showed no change in binding to
the M3_E18 substrate in the two samples, nor was there an
observable difference in ASF/SF2 in the input samples (lanes
17–22).
To confirm the difference in nuclear levels of hnRNP A1,
quantitative Western blotting was used to measure A1 levels
in nuclear extracts from resting and excited cultures relative
to known levels of recombinant A1 (Figure 6C). These results
verify that an increase in nuclear A1 protein levels in the
cultures is associated with the depolarization treatment.
Evidence for the Role of the NMDA Receptor and Calcium
Signaling in the Induced Splicing Response
We would expect cell excitation initiating at the cell
membrane to communicate changes to splicing factors in the
nucleus via calcium-mediated signal transduction pathways.
In the absence of antagonists, the NMDA receptor channel
opens in response to membrane depolarization and serves as
the major conduit for calcium entry into neurons. Because
NMDA receptors are functionally intact in neurons in these
cultures, we wished to take advantage of this property of the
culture system to ask whether NMDA receptors play a role in
the induced effects on splicing observed here. To address this
question, we expressed the CI wt0 splicing reporter in 5-d
cortical cultures under the control of the CaMKII_22
promoter, and the cultures were pre-incubated with antag-
onists specific for the NMDA receptor before KCl-induced
depolarization. MK801 and AP5 antagonists were used for
these experiments because of their known specificity and
effectiveness in inhibiting the NMDA receptor calcium
channel in cortical cultures [31,32]. AP5 binds competitively
to the extracellular glutamate (NMDA) site of the NR2
subunit, whereas MK801 binds to the channel itself, blocking
ion flow. The exon-skipping response of the CI cassette exon
was strong in the control (mock treated) samples (Figure 7A,
lanes 1–3), but in the presence of either antagonist, this
response was attenuated in a dose-dependent manner (lanes
4–15). Relative to the control sample (DEI, 25%), exon
skipping decreased in the presence of MK801 (DEI, 10%)
and in the presence of AP5 (DEI, 4%). In contrast, when
cultures were pre-incubated with bicuculline, which is an
antagonist of the GABAA receptor, only slight effects were
observed on induced exon skipping (DEI,22%; lanes 16–21)
relative to the control (DEI,25%; lanes 1–3). Thus, to a first
approximation, the effects of MK801 and AP5 implicate a
role for the NMDA receptor in mediating the exon-skipping
response of the CI cassette exon in this system.
To extend these results, we used cell-permeable inhibitors
to ask whether calcium-mediated signal transduction path-
ways downstream of NMDA receptors are involved in the
induced splicing silencing response of the CI cassette exon.
Relative to the mock-treated control, the exon-skipping
response was strongly inhibited in the presence of 15 lM
KN93, which is an active site-based inhibitor of CaMK I, II,
and IV (Figure 7B, lanes 22–24 and 40–42), and this effect was
lessened when the inhibitor concentration was reduced to 3
lM (lanes 37–39). The control compound, KN92, had little or
no effect in these experiments (P. An and P. J. Grabowski,
unpublished data). We also found that the exon-skipping
response was inhibited by H89, which has been widely used as
an inhibitor of PKA (lanes 31–36). In an attempt to confirm
this effect, the inhibitor KT5720, which is reported to have a
higher specificity for PKA, was also tested. Interestingly,
KT5720 had little or no effect at 2.5 and 10 lM concen-
7–12) and (2) Gfa2 (lanes 13–18), are shown with those of the corresponding endogenous (E) GRIN1 mRNA (lanes 1–6). Induced changes in splicing (DEI,
%) were calculated as described above (Figure 1). The exon-included (,,) and -skipped (,) mRNAs are indicated. SD, standard deviation.
(B) Viability of CaMK-expressing cortical neurons following KCl-mediated depolarization. Cortical neurons were transfected with CaMKII_22 EYFP
plasmid, and treated under mock or depolarization conditions (0 and 50 mM KCl, respectively) as described for (A). Cultures were stained with trypan
blue and more than 200 EYFP-expressing neurons were scored for trypan blue staining. The percentage of viable cells for each condition is shown; n¼
total cells scored. Representative neurons from these cultures are shown. Left panels of each condition show CaMKII-EYFP fluorescence. Right panels
show bright field (trypan blue) and fluorescence together.
doi:10.1371/journal.pbio.0050036.g003
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trations (lanes 25–30), indicating that the inhibitory effect of
H89 on splicing silencing observed here may involve a
distinct pathway (or pathways).
To determine if additional calcium channels could play a
role in the splicing response of the CI cassette exon, we tested
the effects of specific antagonists of the AMPA/kainate
receptor and voltage-gated calcium channels (L- and N-type)
(Figure S3). Relative to control samples, the exon-skipping
response was reduced, but not eliminated, in the presence of
nimodipine (antagonist of L-type calcium channels) and
conotoxin (N-type calcium channels), whereas CNQX (AMPA/
kainate receptors) showed little or no effect. Taken together,
these results are consistent with roles for multiple calcium
channels in the induced splicing response of the CI cassette
exon in neurons.
Depolarization Alters Splicing Patterns of Additional
Transcripts with Synaptic Functions
Next, we expanded the analysis of endogenous transcripts
in the cortical cultures to test whether additional alternative
cassette exons were responsive to depolarization, and if so, to
determine whether exonic UAGG silencing motifs were
required. We were also prompted to examine transcripts
that encode protein components with synaptic functions,
Figure 4. Nucleotide Sequence Requirements for KCl-Induced Depolarization Effects on Splicing in Primary Neurons
(A) Splicing silencer requirement for the induced response. Splicing reporters based on CI wt0 were expressed in primary neurons via the CaMKII_22
promoter, and depolarization was induced by addition of KCl as in the experiment of Figure 3. Structures of splicing reporters are identical except for
point mutations in silencing motifs as shown in the schematic. UAGG silencing motifs at positions 51 and 93 of the CI cassette exon and a GGGG motif
in the downstream intron are shown for the wild-type substrate, CI wt0. Mutations in splicing reporters, E8, E9, E17, D0, and T8, are underscored. All
splicing reporters [25] were subcloned and expressed from the CaMKII_22 promoter. Graph displays effects of depolarization on the splicing of the wild-
type and mutant substrates. RT-PCR analysis was performed with forward primer (1) and the common reverse primer as for Figure 3. A representative
gel panel is shown. Exon-included (..) and exon-skipped (.) mRNAs are indicated. DEI values are shown.
(B) Effects of exonic splicing enhancers. Point mutations in six exonic enhancers of the CI cassette exon were tested as described in (A). Sequence and
position of SC35, ASF/SF2, and SRp40 motifs are shown at left; mutations within each motif are underscored. Effects of mutations as a function of
depolarization in neurons and DEI values are shown.
SD, standard deviation.
doi:10.1371/journal.pbio.0050036.g004
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since the NMDA NR1 receptor and other calcium channels
were implicated in the splicing response of the CI cassette
exon from the experiments described above. Of 14 new exons
tested, seven showed a significant exon-skipping response,
five showed little or no response, and two showed an increase
in exon inclusion (Figure 8).
Strong exon-skipping responders were found to contain
hnRNP A1–type silencing motifs in or near the responsive
exon (Figure 9). Exon 3 of hnRNP H3 and exon 2 of the
RNPS1 transcripts (DEI, 32% and 25%, respectively)
contain either one exonic UAGG and a 59 splice site GGGG
motif (H3), or two exonic UAGGs (RNPS1). Exon 35 of PLCb4
also showed a strong response (DEI, 26%), and this exon
contains two TAGA motifs, which reflects a four of six match
to hnRNP A1 motifs reported for SMN2 exon 7 and human
CD44 v5 exon [33]. These motifs cannot be the sole
determinants of the response, however. Exon 4 of hnRNP
H1, which is identical in size (139 nucleotides) and highly
homologous to exon 3 of hnRNP H3, showed little or no
response (DEI,3%) in the same samples. Interestingly, there
is one exonic UAGG and a GGGG tetramer near the 59 splice
site of this exon, but it lacks a third silencing motif (exonic
GGGG) that is found in exon 3 of hnRNP H3. Moreover,
constitutive exon 8 of the MEN1 transcript remains entirely
unresponsive even though this exon contains two exonic
UAGGs and a 59 splice site proximal GGGG motif.
Of the exons that showed little or no response, exon EN of
clathrin light chain B (CLCB) was the most interesting. In a
previous report, this exon showed increased exon skipping in
the cortex and hippocampus of rats treated with pilocarpine
[13]. In cortical cultures under the conditions tested here,
however, exon EN showed a stable splicing pattern even
though it is a well-skipped exon (exon inclusion, 30%). Other
alternative exons with a predominant skipping pattern that
were unresponsive in these cultures include exon 21 of
MAP4k4, exon 8 of hnRNP A1, exon N1 of GRIN1, exon 7 of
Chl, and exon 7 of Agrin. These exons, including EN of CLCB,
lack hnRNP A1 motifs. Thus, the exon-skipping responsive-
ness of certain exons to depolarization treatment cannot be
explained solely by a weakening of the general splicing
machinery that causes all skipped exons to undergo stronger
exon-skipping responses.
Finally, two exons showed moderate increases in exon
inclusion during the depolarization treatment. These in-
cluded exon 9 of the GABAA receptor c2 transcript, and the
STREX exon of the c-slo transcript (DEI, 18%, and 12%,
respectively). These results suggest that some of the bio-
chemical changes resulting from the depolarization treat-
ment in neuronal cells can, in principle, increase exon
inclusion.
Discussion
UAGG-Type Silencing Motifs Mediate Exon-Skipping
Responsiveness to Neuronal Excitation
At the level of pre-mRNA splicing, the CI cassette of the
NMDA R1 receptor is one of several responsive exons that
undergo an increase in exon skipping in response to
neuronal excitation. Despite the importance of NMDA
receptors in neuronal excitability at the level of ion channel
function, the mechanisms by which stimuli are communi-
cated to the nuclear splicing machinery to affect changes in
alternative splicing are poorly understood. Moreover, meth-
odologies to address these questions in primary neurons, in
which NMDA receptors are functionally intact, have not been
well developed.
Here we describe a promoter-based expression assay that
reports splicing changes in response to cell excitation with
tight specificity for the neurons of cortical cultures derived
from embryonic rat brain. Due to its neuron-specific
expression in the forebrain regions of transgenic mice, the
alpha CaMKII promoter was tested for its ability to provide a
neuron-specific readout in a primary culture setting. In
cortical cultures, full-length as well as truncated forms of this
promoter displayed a strong preference for expression in
neurons versus glial cells as demonstrated by co-localization
Figure 5. Transfer of Multicomponent UAGG Silencing Motif Pattern
Confers Sensitivity of a Constitutive Exon to Depolarization in Primary
Neurons
(A) The schematic at top illustrates the heterologous splicing reporters
used for the transfer experiments. Exon 5 of the DIP13 transcript and 12
nucleotides of each flanking intron was inserted between the NdeI and
XbaI restriction sites of the SIRT1a_CaMKII22 plasmid. An engineered
EcoR1 site is indicated by the arrowhead in the sequences shown. Intron/
exon lengths (nucleotides) are as follows: exon 1, 308; intron 1, 340; exon
2, 94; intron 2, 287; and exon 3, 436. For the middle exon sequences
shown in the expanded region for wild-type exon 5, the predicted exonic
enhancer motifs are highlighted in black letters. UAGG silencing motifs
were introduced into the middle exon of the DIP_3aG, and DIP_E2
splicing reporters as indicated (red letters); mutations are underscored.
Colon indicates 59 splice site cleavage position. The first 12 nucleotides
of the downstream intron are shown at right for the wild-type substrate
(DIP13_E5). The GGGG motif at intron nucleotides 6–9 is highlighted in
red.
(B) Representative results of RT-PCR analysis and values for percent exon
inclusion and DEI are shown; the exon-included (,,) and -skipped (,)
mRNAs are indicated. SD, standard deviation.
doi:10.1371/journal.pbio.0050036.g005
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Figure 6. Biochemical Analysis of Protein Binding to UAGG Silencer Motifs as a Function of Cell Excitation
(A) Schematic of methodology used to analyze protein binding to RNA substrates in nuclear extracts from KCl-induced and mock-treated cultures. UV
crosslinking assays were performed under splicing conditions to monitor protein binding to radiolabeled RNA oligos (lanes 1–8), and to the full-length
CI cassette exon (lanes 9 and 10). Sequences of RNA oligos and schematic of CI exon are shown at right of gel panels. Gel panels show radiolabeled
proteins after SDS-PAGE separation; kDa ladder indicates molecular weight standards.
(B) Affinity selection of proteins non-covalently bound to RNA substrates containing the full-length CI cassette exon with (M3_E18) or without (E18) the
M3 hairpin. Assembly reactions containing RNA substrates pre-bound to MS2-MBP were incubated under splicing conditions, bound to amylose
columns, and eluted with maltose. Samples were resolved by SDS-PAGE and transferred to nylon membranes for immunoblotting with hnRNP A1-
specific 9H10 (lanes 11–16) or ASF/SF2 (lanes 17–22) antibody. A1 and A1B represent the major and minor isoforms of hnRNP A1, respectively.
(C) Quantitative Western blots show serial dilutions of recombinant hnRNP A1 (MBP-A1) grown in Escherichia coli as reference standards from 1 to 20 ng
(top panel). Nuclear levels of hnRNP A1 and A1B are shown at three loading levels, 100, 200, and 400 ng of total nuclear extract (NE) protein (bottom
panel). Nuclear extracts were prepared from mock-treated (Mock) and 50 mM KCl-treated cultures (Depol). Monoclonal antibody 9H10 was used to
detect hnRNP A1 in both blots.
doi:10.1371/journal.pbio.0050036.g006
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of promoter-directed EYFP expression together with anti-
body staining for cell-specific markers. Moreover, these
effects were dependent upon the primary culture context,
since neuron-specific splicing patterns were eliminated when
the same promoter-EYFP cassettes were expressed in neuro-
nal versus non-neuronal cell lines.
Using splicing reporters driven by the CaMKII promoter,
we show that neuronal cells play the predominant role in the
Figure 7. Test of Inhibitors of NMDA Receptors and Signaling Pathways on the CI Cassette Exon-Skipping Response in Excited Neurons
(A) Schematic summarizes the experimental procedure: cortical cultures were transfected with CaMKII_22 CI wt0, and pre-incubated with inhibitor at
final concentrations as indicated just above gel panels. With the inhibitor remaining in the culture medium, KCl was then added (25 or 50 mM) to induce
depolarization. Gel panels and graph in (A) show effects of NMDA receptor antagonists MK801 and AP5. Pre-inc, pre-incubated.
(B) Gel panels and graph shows the effects of cell-permeable inhibitors, KT5720, H89, and KN93. Experiments were performed as described for (A). The
exon-included (,,) and -skipped (,) mRNAs are indicated.
doi:10.1371/journal.pbio.0050036.g007
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acute splicing response to excitation, and these splicing
pattern changes reflect the trend and magnitude of those
observed for the corresponding endogenous transcripts. In
neurons of these primary cultures, the exon-skipping
response of the CI cassette exon was mediated by combina-
tions of UAGG-type silencing motifs. The general importance
of a strong silencing motif pattern was confirmed by a gain-
of-responsiveness due to the transfer of a similar UAGG-type
silencing motif pattern into a constitutive exon. In this
heterologous context, the transfer of multiple exonic UAGG
motifs and a 59 splice site proximal GGGG motif generated a
basal-level exon-skipping pattern in the absence of depola-
rization, and exon skipping was further increased, over and
above this basal level, as a function of depolarization.
Furthermore, by expanding this analysis to fourteen alter-
natively spliced exons, several exons with strong exon-
skipping responses were found to contain multiple hnRNP
A1 silencing motifs consistent with a plausible role for
hnRNP A1 in these effects. These results extend our previous
work, which identified a multicomponent UAGG and GGGG
motif code for basal-level splicing silencing of the CI cassette
exon in established cell lines [29]. Additional studies have
documented a similar exon-skipping response of the CI
cassette exon to cell excitation in rat brain [13] and in GH3
pituitary cells, but in these previous studies nucleotide
sequences required for the effects were not defined.
The first RNA element shown to confer an exon-skipping
response to KCl-mediated depolarization was defined for the
STREX exon of the BK potassium channel. This element,
termed CaRRE (CaMKIV-responsive RNA element), was
defined as a 54-nucleotide pyrimidine-rich region in the 39
splice site of the STREX exon, and a pyrimidine-rich exonic
RNA element, termed D56, was also found to contribute to
this splicing response in GH3 cells [12]. The CaRRE sequence
was later refined by mutagenesis in primary mouse cerebellar
cultures to comprise the sequence (59) CACATNRTTAT (39)
[34]. We note that neither the CaRRE, nor the D56 element,
are present in the 39 splice site upstream of the CI cassette.
Moreover, the UAGG-type silencing motifs defined here for
the responsiveness of the CI cassette are absent from the
STREX exon. These observations suggest that the exon-
skipping responsiveness of these two exons is likely to involve
distinct silencing mechanisms. The accompanying paper by
Lee et al.[35] reports the identification of two types of CaRRE
elements required for inducible exon-skipping in P19 cells,
one of which is adjacent to a UAGG splicing silencer in the CI
cassette. Whether the sequence requirements for inducible
exon-skipping are more complex than these studies indicate
or whether the differences in cell types or assays can account
for seemingly different requirements is unknown.
In efforts to extend the results of the RNA motif analysis,
we used biochemical approaches to attempt to visualize any
changes in the proteins that bind directly to the identified
UAGG motifs. In UV crosslinking experiments, the binding of
hnRNP A1 to UAGG motifs was found to increase in nuclear
extracts from the excited versus resting cells (2-fold increase),
and this was verified by affinity selection and immunoblot-
ting. In contrast, no change in the binding of splicing factors
ASF/SF2 and TRA2 to their respective RNA substrates was
observed in parallel reactions using these nuclear extracts. In
addition, the cell-permeable PKA inhibitor H89, which was
shown to block the excitation effects at the level of splicing,
was also found to eliminate the increase in hnRNP A1
crosslinking in nuclear extracts that were excited in the
presence of this compound. Taken together with the UAGG
motif analysis, these results are in agreement with the
prediction that signal transduction pathways communicate
with splicing regulatory factors to cause induced effects on
splicing, although at this point, many questions remain about
how this communication is relayed to the nucleus, and exactly
Figure 8. Exon-Skipping Responsiveness of Fourteen Endogenous Exons
in Cortical Cultures During Depolarization Treatment
Gel panels represent RT-PCR analysis of endogenous exons with gene
and exon numbers as indicated above each panel. Each panel represents
24-h treatment of cortical cultures with 0, 25, and 50 mM KCl (lanes, left
to right). One PCR primer in each sample was 59 end labeled with 32P.
Raw exon inclusion values (EI) and change in exon inclusion values (DEI;
boldface) are given below each panel. E8 of MEN1 and E2 of actin are
constitutive exons; all other exons are alternative cassette exons. A single
asterisk (*) indicates 6-h KCl treatment.
doi:10.1371/journal.pbio.0050036.g008
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how the hnRNP A1 polypeptide is affected by the induction.
Previous studies have documented an increase in the
cytoplasmic distribution of A1 together with specific changes
in the phosphorylation pattern upon osmotic stress [19,20].
Despite the apparent differences in the nature of the changes
in hnRNP A1 during osmotic stress versus neuronal excita-
tion, these previous studies and the results shown here,
reinforce the idea that A1 is adept at responding to
environmental signals.
Implications for the Calcium Channel of the NMDA
Receptor in Splicing Responsiveness to Neuronal
Excitation
NMDA receptors are multisubunit protein complexes
concentrated in the postsynaptic membrane where they
regulate calcium influx into neurons in response to the
binding of glutamate and glycine. Calcium influx through
NMDA receptors is believed to trigger acute biochemical
changes leading to long-term changes in synaptic strength, or
plasticity [36]. In this study, we have taken advantage of the
cortical culture system to explore the potential role of NMDA
receptors in the CI cassette exon-skipping response to
neuronal excitation. If the excitation regimen used here to
induce the CI cassette exon-skipping response involves
calcium influx through NMDA receptors, we would expect
antagonists that specifically block the NMDA calcium channel
to weaken the excitation effects on splicing. Consistent with
this idea, we observed a substantial, dose-dependent block in
the response of this exon-skipping event when the cultures
were treated with the antagonists AP5 or MK801. In contrast,
when bicuculline was applied as an antagonist of the GABAA
receptor, the exon-skipping response was only slightly
weakened. The complete inhibition of the CI cassette exon-
skipping response by KN93 is consistent with a role for
calcium-mediated signaling in these effects. The effects
shown here for KN93 in cortical neurons are in good
agreement with previous studies from the Black laboratory,
which have demonstrated a role, specifically, for CaMKIV in
Figure 9. Summary of Exon-Skipping Responsiveness and UAGG Code
(A) Percent exon inclusion values are shown graphically for the samples represented in Figure 8.
(B) Percent DEI values represent exon-skipping responses to depolarization for samples in Figure 8. Negative values (10%) reflect significant exon
skipping, whereas positive values (10%) reflect exon inclusion. The number of UAGG (hnRNP A1-type) silencing motifs are indicated (bottom).
doi:10.1371/journal.pbio.0050036.g009
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the exon-skipping response to excitation in GH3 cells and in
cerebellum tissue from mouse CaMKIV knockout lines
[12,34]. Because treatment with AP5 or MK801 largely, but
not completely, blocks the CI cassette exon-skipping response
to excitation, it is a viable possibility that calcium influx into
neurons via AMPA receptors and/or L-type calcium channels
might also be involved.
Modular changes in a variety of proteins involved in
synaptic function have been documented at the level of
alternative splicing. A large-scale analysis of splicing pattern
changes in the neocortex of Nova2 knockout mice has
revealed that approximately 34 exons with splicing defects
correspond to transcripts that encode synapse-related pro-
teins [37,38]. Of these, the CI cassette exon was found to
undergo increased exon skipping (;45% increase) in the
Nova2 knockout mice, suggesting a role for Nova2 as a
positive regulator of this exon in the mouse forebrain. In
addition, NAPOR/CUGBP2, hnRNP H, and to a lesser extent
ASF/SF2 and SC35, have been shown to function as positive
regulators of the CI cassette exon at the level of splicing
[29,39]. Along with the splicing silencing features of this
control mechanism, a significant amount of combinatorial
control of the CI cassette exon is indicated. Although it is not
known how the nuclear levels of these additional factors are
affected by neuronal excitation, an assumption of the present
study is that selective alteration(s) to the balance of enhance-
ment versus silencing underlies the net changes observed in
the splicing patterns.
To a first approximation, our results indicate that NMDA
receptors are involved in the CI cassette exon-skipping
response to KCl-induced depolarization in these cultures.
This raises questions about the potential biological role of this
exon-skipping response. The CI cassette exon itself has been
shown to be important for localization of the NMDA R1
subunit of the receptor at the plasma membrane, and the role
of this exon in intracellular signaling has been documented
[40,41]. Previous studies have shown that NMDA receptor
recruitment to synaptic sites can be substantially affected by
neuronal activity. Rao and Craig found increased accumu-
lation of NMDA receptors at synaptic sites in hippocampal
cultures when neuronal excitation was chronically blocked by
treatment with AP5, although effects at the level of splicing
were not detected [42]. In another study, the Ehlers laboratory
showed that trafficking of NMDA receptors to synapses
during activity blockade in cortical cultures was associated
with spliced variants of the NMDA R1 receptor that contain
the C29 exon, but not the alternative exon, C2 [43].
The synaptic homeostasis model holds that, in order to
stabilize excitability, neurons tend to downwardly adjust their
synaptic strengths under conditions of chronic excitation, or
upwardly adjust them under conditions of activity blockade
[44]. This model, together with the results shown here,
suggests that alternative splicing of the CI cassette exon
might be involved in strategies by which neurons mount
protective responses to an overload or lack of environmental
stimuli. In agreement with the results shown here, a chronic
KCl-induced depolarization of cortical cultures was shown to
accompany a decrease in the NR1–1 (þCI cassette), and an
increase in the NR1–2 (CI cassette), mRNA isoform of the
NMDA R1 receptor [45]. We have no direct evidence that a 2-
fold increase in exon skipping of the CI cassette exon would
cause a meaningful change in the number of NMDA receptors
at the synapse. Nonetheless, it is apparent from other studies
that subtle changes at the level of splicing can bring about
important changes at the level of protein expression. In mice,
a splicing defect in the sodium channel gene, Scn8a, was
shown to produce viable animals with only 10% of correctly
spliced mRNA in one genetic background, whereas a
reduction to 5% of the correctly spliced mRNA in a different
genetic background was lethal [46]. In this case, the cause of
lethality was shown to be due to a mutation in the modifier
gene, Scnm1. Furthermore, rescue from lethality was achieved
by transgenic expression of a wild-type form of Scnm1, which
brought about a 5% increase in the correctly spliced Scn8a
mRNA. In another example, a bifunctional antisense oligo-
nucleotide was introduced into fibroblasts derived from
spinal muscular atrophy patients in an attempt to reprogram
the splicing of exon 7 of SMN2 pre-mRNA. The SMN (survival
of motor neurons) protein is a key component of nuclear
gems, which are required for the biogenesis of small nuclear
ribonucleoproteins. In the presence of the bifunctional
oligonucleotide, exon 7 inclusion increased from 57% to
84%, and the percentage of gem-positive nuclei increased
accordingly from 2%–3% to 13% [47]. Thus, subtle changes
in splicing can be biologically important.
In this study, E9 of the GABAA receptor c2 subunit
transcript showed an increase in exon inclusion in response
to neuronal excitation, clearly opposite to that of the CI
cassette. Based on the distinctive features of these two splicing
control mechanisms at the biochemical level (E9 involves
silencing polypyrimidine tract binding protein), the opposite
responses to excitation may be due to modifications of
splicing factors that are unique for each exon. Alternatively,
hnRNP A1 may be involved indirectly in the regulation of E9
inclusion. At the level of cellular function, GABAA receptors
are the principal mediators of inhibitory neurotransmission,
and the c2 subunit plays important roles in clustering of
GABAA receptors and the scaffold protein gephyrin at
postsynaptic sites [48,49]. Although the E9 region was
originally reported to confer ethanol sensitivity to the GABAA
receptor [50,51], no discrete function for this region of the
protein has been revealed in transgenic mice expressing the
c2S (E9), but not c2L (þE9) subunit isoform [52]. Thus, the
possibility that the changes in splicing we observe here for
GABAA receptor c2 could be related to the adaptive response
of neurons to hyperstimulation is purely speculative.
Future work will be needed to describe the full spectrum of
exons that respond to neuronal excitation genome-wide, and
the splicing factors and signaling pathways involved.
Although this silencing motif code is relatively rare, well
over 100 human exons contain two or more UAGGs that
could potentially confer responsiveness in neurons. This also
raises the question of whether the failure of cells to reverse
acute splicing responses to environmental stimuli or stress
may play roles in the misregulation of splicing that contrib-
utes to disease. It will also be of interest to explore the
relationships between induced splicing effects and the
function and distribution of relevant neurotransmitter
receptors at the synapse.
Materials and Methods
Plasmid construction. Fluorescent reporters: CaMKII_EYFP re-
porters were constructed by inserting the open reading frame of
EYFP and poly(A) site downstream of the 8.5 kb SalI-NotI fragment of
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the mouse CaMKII promoter [26] in a pBlueScript (pBS) plasmid.
Promoter deletions were obtained by cleavage with FspI as shown in
Figure 2. CaMKII-Cre promoter constructs were generated from
corresponding Cre fusions, which were the generous gift of Joe Tsien
and Zhenzhong Cui. Construction of Gfa2-DsRed involved inserting a
2.2-kb EcoRI fragment with the Gfa2 (glial fibrillary acidic protein)
promoter upstream of the coding sequence of DsRed2 (red
fluorescent protein) and downstream SV40 poly(A) site. The latter
fragment was amplified by PCR from pDsRed2 (BD Biosciences, San
Diego, California, United States).
Splicing reporters: Wild-type (wt0) and mutant CI cassette splicing
reporters originally described in [29] were subcloned into promoter-
specific plasmids CaMKII_22 or Gfa2. DIP13 splicing reporters were
generated by insertion of the human DIP13 beta exon 5 and flanking
introns into the NdeI and XbaI sites of the SIRT1a plasmid, followed
by transfer of the HindIII-NotI fragment containing the complete
splicing reporter sequence downstream of the CaMKII promoter. The
exon 5 insert was synthesized in two parts, as two double-stranded
deoxyoligonucleotides, and these were ligated together via comple-
mentary EcoRI cohesive ends. Site-directed mutations were gener-
ated with the QuikChange Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, California, United States) Sequences of all splicing reporters
were verified by DNA sequencing. Constructs pBS_E18, and pBS-
M3_E18 were generated by PCR from the corresponding full-length
splicing reporters and cloned into the HindIII site of pBluescript
vectors. All inserts were verified by DNA sequencing.
Primary cultures, KCl treatment, and fluorescence imaging.
Approximately one dozen rat embryonic day 17 cerebral cortex
tissues (Zivic Miller, Pittsburgh, Pennsylvania, United States) were
treated with trypsin (0.25% trypsin, w/v, in 0.1% glucose, 2 mM L-
glutamine and 20 mM HEPES in MEM) at 35 8C for 20 min. Cells were
dissociated by passing the treated samples five to six times through an
18-gauge needle. The cell suspension was washed twice with ice-cold
growth medium (0.5 mM L-glutamine, 2% B27 supplement in
Neurabasal Medium; Invitrogen, Carlsbad, California, United States),
and plated in poly-D-lysine–coated 6-well plates (BD Biosciences) at a
density of 4–63105 cells/well. For antibody staining, cells were plated
on poly-D-lysine–coated coverslips. L-glutamic acid (25 lM final
concentration) was added to the growth medium for the first 4 d of
culture. Cultures were maintained at 37 8C with 5% carbon dioxide.
To induce depolarization, KCl was added directly to the growth
medium at the indicated concentrations. Inhibitor compounds were
obtained from Sigma (bicuculline; St. Louis, Missouri, United States),
or Calbiochem (H89, KN93, MK801, AP5, and KT5720; San Diego,
California, United States).
For immunostaining, cortical cultures on coverslips were fixed
with 3.7% formaldehyde in PBS for 7 min at room temperature, and
permeabilized with 0.1% TritonX-100 in phosphate buffered saline
(PBS) for 1 min at 20 8C followed by incubation for 5 min at 4 8C.
Coverslips were washed thoroughly with PBS, and blocked for 2 h at
room temperature in Blocking Buffer (1% BSA, 0.1% gelatin in PBS)
containing 5% normal goat serum. The neuron-specific mouse anti-
NeuN (1:100 dilution) or glial-specific rabbit anti-GFAP (1:1,000
dilution) antibodies were applied to coverslips and incubated
overnight at 4 8C. After three washes in incubation buffer at room
temperature, TRITC- or FITC-labeled goat anti-mouse or goat anti-
rabbit (Chemicon, Temecula, California, United States) secondary
antibodies (1:1,000 dilution) were applied. After washing in Blocking
Buffer (three times for 5 min each) at room temperature, coverslips
were dried and mounted on slides in 10% MOWIOL 4–88 (EMD
Biosciences, San Diego, California, United States), 25% glycerol, 2.5%
DABCO (Sigma), and 0.1 M Tris-HCl (pH 8.5). The number of cells
with EYFP and TRITC fluorescence, or the number of cells with
DsRed and FITC fluorescence, were scored by confocal microscopy
(Radiance 2000; Bio-Rad, Hercules, California, United States) with
FITC/EYFP (460–500 nm) or TRITC/DsRed (530–550 nm) excitation
filters.
Transfection and RNA analysis. Plasmid DNA (1.25 lg) was
transfected into cortical cultures using 3 ll of Lipofectamine 2000
(Invitrogen) per well of a 6-well plate. Plasmid DNA and Lipofect-
amine were each diluted to a final volume of 100 ll with OPTI-MEM,
then combined and incubated for 20 min at room temperature.
Cultures were prepared for transfection by washing once with OPTI-
MEM, followed by addition of 2-ml fresh OPTI-MEM and transfection
mixture to each well. Medium was replaced with fresh growth
medium after 5 h.
For splicing pattern measurements, cells were harvested 24–48 h
post-transfection using TRIZOL (Invitrogen). Splicing patterns were
measured in triplicate by RT-PCR as described [39]. Reverse
transcription (RT) reactions (20-ll total volume) contained M-MLV
reverse transcriptase (Invitrogen), 2-lg RNA sample, and 0.5-lg
random hexanucleotide primers (Promega). PCR reactions (10-ll
volumes) contained 0.2 lM specific primers, 2 units of Taq DNA
polymerase (Promega, Madison, Wisconsin, United States), 1/20th of
the volume of the RT reaction, 0.2 mM dNTPs, and 1-lCi of [a-32P-
dCTP]. Amplification was for 25 cycles. Primers were designed to
amplify exon-included and -skipped mRNAs in each sample. Primers
NR1 3021 (59) ATGCCCGTAGGAAGCAGATGC (39) and NR1 3255
(59) CGTCGCGGCAGCACTGTGTC (39) were used amplify endoge-
nous C1 cassette mRNAs. Primers rp1 (59) GTATGGTACCCTGCAC-
TATTTTGTG (39) and rp2 (59) TTGGATCGTTGCTGATCTGGGACG
(39) were used to amplify the GABAA receptor c2 mRNAs. CaMKII-
and Gfa2-specific mRNAs were amplified with promoter-specific
upstream primers: CaMKII, (59) GCACGGGCAGGCGAGTGG (39);
Gfa2 (59) TTGGAGAGGAGACGCATCACCTCC (39) together with the
gene-specific downstream primer. PCR products were resolved on
6% polyacrylamide/7 M urea gels. Gel images were captured with a
BAS-2500 Phosphorimager (Fuji Medical Systems, Roselle, Illinois,
United States), and quantitation determined with Science 2003
ImageGauge 4.0 software.
Nuclear extract preparation, UV crosslinking, and affinity chro-
matography. Scaled-down nuclear extracts were prepared essentially
as described for rat cortical tissue [53]. Cortical cultures (five 10-cm
dishes equivalent to 2 3 107 cells total) were harvested using plastic
cell lifters (Corning, Corning, New York, United States) in 13 PBS (1
ml/dish). After centrifugation, cell pellets were resuspended in 4 ml
of ice-cold Buffer I (10 mM Tris-HCl [pH 8.0], 0.32 M sucrose, 3 mM
CaCl2, 2 mM Mg-acetate, 0.1 mM EDTA, 0.5% NP40, 1 mM DTT,
and 13 protease inhibitor cocktail). Cell suspensions were trans-
ferred to pre-chilled 15-ml Wheaton glass homogenizers, and cells
were broken on ice with pestle A (tight fitting) three to five times
every 10 min for a total of 30 min. Cell lysates were mixed with 4 ml
of Buffer II (10 mM Tris-HCl [pH 8.0], 2 M sucrose, 5 mM Mg-
acetate, 0.1 mM EDTA, 1 mM DTT, and 13 protease inhibitor
cocktail), and layered on top of 3.5 ml of Buffer II in 12-ml
ultracentrifuge tubes. Samples were centrifuged in a SW41 rotor at
30,000 g for 45 min at 4 8C. Nuclear pellets were rinsed twice with
0.5 ml of Buffer C (20 mM Hepes [pH 7.6], 20 mM KCl, 1.5 mM
MgCl2, 25% v/v glycerol, 0.5 mM DTT, 0.2 mM EDTA), resuspended
in 50-ll Buffer C plus 0.25 M KCl, and transferred to 1.5-ml
Eppendorf tubes. The concentration of nuclei in each sample was
determined by trypan blue staining and adjusted with buffer to
equal concentrations. Nuclear suspensions were incubated for 30
min on ice with occasional mixing, then centrifuged at 14,000 rpm
for 10 min at 4 8C. Nuclear extracts (50 ll volumes) were collected
and used for UV crosslinking experiments. Protein concentrations
were typically in the range of 0.5 to 0.75 mg/ml as determined by
Bradford assay.
Short RNA substrates (22-mers) were synthesized by Dharmacon
and 59 end labeled with c-32P-ATP and T4 polynucleotide kinase.
Longer RNAs were internally labeled with a32P-UTP during in vitro
transcription using T7 RNA polymerase (Stratagene). RNA-protein
complexes were assembled for 5 min at 30 8C in 12.5-ll reactions by
combining labeled RNA substrates (100,000 disintegrations/min
[dpm]) and nuclear extract (3.5 ll) under splicing conditions (20
mM Hepes [pH 7.5], 1.5 mM ATP, 5 mM creatine phosphate, 2 mM
MgCl2, and 4.5 ll of 4.5 k Buffer (25% glycerol v/v, 0.02 M Hepes [pH
7.5]). Samples were irradiated on ice with 1.8 joules at 365-nm
wavelength. Samples were positioned at a distance of 8 cm from the
UV light source. After adding SDS-PAGE loading buffer (volume),
samples were boiled 5 min at 95 8C and resolved by electrophoresis
on SDS-PAGE (10% polyacrylamide separating gels). Gels were fixed
in 45% methanol, 9% acetic acid for 2 h, and dried. Radioactive
images were captured as described above. For affinity selection
experiments, the CI cassette exon (variant E18) was cloned upstream
of the M3 hairpin and synthesized by in vitro transcription by T3
RNA polymerase. Transcripts were purified on Sephadex G50–150
spin columns and ethanol precipitated. MS2-MBP was purified as
described [30].
Supporting Information
Figure S1. Depolarization Response of Endogenous GABAA Receptor
Gamma 2 Exon 9, and Verification of CaMKII Reporter Expression in
Neurons
(A) The depolarization response of endogenous GABAA receptor
gamma 2 exon 9.
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(B) Verification of CaMKII reporter expression in neurons.
Found at doi:10.1371/journal.pbio.0050036.sg001 (852 KB TIF).
Figure S2. Immunoprecipitation Analysis of hnRNP A1, and Effect of
H89 Inhibitor on UV Crosslinking of A1
Combined UV crosslinking reactions equivalent to sample shown in
lane 2 of Figure 6A were used for immunoprecipitation analysis of
hnRNP A1 (lanes 11–15). Arrowhead indicates position of hnRNP A1.
Effect of H89 inhibitor on UV crosslinking of hnRNP A1 is shown
(lanes 16–18).
Found at doi:10.1371/journal.pbio.0050036.sg002 (210 KB TIF).
Figure S3. Effects of Antagonists of AMPA/Kainate Receptor and
Voltage-Gated Calcium Channels (L- and N-Type) on Induced
Splicing of the CI Cassette Exon
Found at doi:10.1371/journal.pbio.0050036.sg003 (10.9 MB TIF).
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